Loading...

Elanco Animal Health Incorporated

ELAN•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.93
$0.25(1.70%)

Elanco Animal Health Incorporated (ELAN) AI-Powered Stock Analysis

See how Elanco Animal Health Incorporated scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Elanco Animal Health Incorporated (ELAN) Stock Overall Grade

Elanco Animal Health Incorporated’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B+

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Elanco Animal Health Incorporated's overall stock rating.

Forecast

B

Score

63/100

Financial Growth

B+

Score

75/100

Fundamental Growth

C

Score

40/100

Key Ratios

B+

Score

77/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

B+

Score

70/100

Elanco Animal Health Incorporated (ELAN) AI-Powered Stock Analysis

This asset demonstrates Good performance with an overall Forecast Score of 63/100 (B), reflecting high confidence in its potential. Financial Growth (75/100, B+) and Fundamental Growth (40/100, C) highlight its stability, while Key Ratios (77/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (70/100,B+) suggests High divergence in outlook.

Component Analysis Explained

Understand the key factors behind each Elanco Animal Health Incorporated stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;